[ XXXX as a precursor of myeloid leukemia].

@entity1 @entity1667 @entity3761 @entity6794 @entity1066 @entity3052 @entity134 @entity205 @entity1188 @entity272 @entity617
A 34-year-old @entity1 who was 20 weeks pregnant developed @entity6794 while receiving treatment for @entity1188 . Because of her septic condition an abortion was performed. The @entity1 received intravenous @entity617 as a pulse treatment for her @entity6794 , which was followed by oral @entity1667 and oral @entity3761 for 6 weeks. After dose reduction the @entity1 had a severe relapse. The @entity134 dose was increased and @entity3761 was replaced by @entity205 . The smaller ulcers healed spontaneously, but skin grafting had to be performed for the large @entity1066 . The @entity134 therapy was tapered and discontinued. @entity205 was continued for 10 weeks as monotherapy. Subsequently, the @entity1 was free of symptoms for 7 months. Twelve months after the diagnosis of @entity6794 the @entity1 developed @entity3052 accompanied by a recurrence of the @entity272 .
